FORTIS vs INDRAMEDCO: Stock Comparison
FORTIS HEALTHCARE is the larger company by market capitalisation. FORTIS HEALTHCARE shows faster revenue growth, while INDRAPRASTHA MEDICAL CORP shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
FORTIS leads 3; INDRAMEDCO leads 8 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | FORTIS | INDRAMEDCO |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Hospital | Hospital |
Price
| Metric | FORTIS | INDRAMEDCO |
|---|---|---|
| Live Price | ₹754.9 | ₹318.3 |
| Day Change | -0.61% | 1.5% |
| Volume | 7.54 L | 90,197 |
| 52-Week High | ₹1,064.5 | ₹640.85 |
| 52-Week Low | ₹704.95 | ₹293.65 |
| Distance from 52W High | -29.08% | -50.33% |
Valuation
| Metric | FORTIS | INDRAMEDCO |
|---|---|---|
| Market Cap | ₹56,890 Cr | ₹2,917 Cr |
| P/E Ratio | 54.29x | 15.51x |
| P/B Ratio | 5.75x | 3.94x |
| EPS | ₹3.53 | ₹6.09 |
| Book Value | ₹134.69 | ₹80.76 |
| Dividend Yield | 0.13% | 1.26% |
Growth
| Metric | FORTIS | INDRAMEDCO |
|---|---|---|
| Revenue Growth (TTM YoY) | 17.8% | 9.3% |
| EPS Growth (TTM YoY) | 44.3% | 1.8% |
| Qtr Sales Growth | 0% | 0% |
| Qtr Profit Growth | 0% | 0% |
Profitability & Leverage
| Metric | FORTIS | INDRAMEDCO |
|---|---|---|
| ROE | 2.5% | 24.8% |
| ROCE | 2.84% | 25.58% |
| Net Margin | 11.41% | 12.21% |
| Operating Margin | 26.51% | 17% |
| Debt to Equity | 0.21x | 0x |
Shareholding
As of Sep 2026 • change vs previous quarter| Metric | FORTIS | INDRAMEDCO |
|---|---|---|
| Promoter Holding | 0% | 49.39% |
| FII Holding | 23.19%▼ 2.01 pp | 2.39%▼ 0.38 pp |
| DII Holding | 34.46%▲ 2.23 pp | 1.77%▲ 1.18 pp |
| Public Holding | 11.18%▼ 0.22 pp | 44.84%▼ 0.8 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: FORTIS HEALTHCARE and INDRAPRASTHA MEDICAL CORP.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.